Monday, June 4, 2018 –Today, Lung Cancer Alliance (LCA) is proud to announce Carl M. Gay, MD, PhD as the recipient of the 2018 Conquer Cancer Foundation of ASCO/Lung Cancer Alliance Young Investigator Award (YIA).
Through this award, LCA will support Dr. Gay’s research into whether inhibiting DNA repair mechanisms in small cell lung cancer can either lead to cancer death or increase the ability for immunotherapies to work better to fight the cancer.
Conquer Cancer Foundation formally announced the honor during the Grants and Awards Ceremony at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting currently taking place in Chicago.
“Dr. Gay’s work is critical for finding new treatment pathways to manage a type of lung cancer that has not yet seen the types of advances that have emerged in other areas of lung cancer,” said Jennifer C. King, PhD, Director of Science and Research, Lung Cancer Alliance. “We are so pleased to welcome him to the Lung Cancer Alliance family because we know that through his work there is an opportunity to fill an unmet need for our patient community.”
“I want to thank Lung Cancer Alliance for their support through the Young Investigator Award program,” said Dr. Gay. “This commitment will enable me to continue research that I hope will lead to positive, treatment advances in the fight against small cell lung cancer.”
The one-year, $50K grant will enable Dr. Gay to conduct research on a type of cancer that accounts for approximately 15 percent of all lung cancers worldwide, but does not yet have a pipeline of successful treatments to improve outcomes for patients who are diagnosed.
This marks the third year that LCA has funded a YIA recipient through this partnership with Conquer Cancer Foundation. To learn more about the Young Investigator Award and past recipients click here.